Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

molecular imaging

  • Open Access
    Superior Tumor Detection for 68Ga-FAPI-46 Versus 18F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma
    Kim M. Pabst, Marija Trajkovic-Arsic, Phyllis F.Y. Cheung, Simone Ballke, Katja Steiger, Timo Bartel, Benedikt M. Schaarschmidt, Aleksandar Milosevic, Robert Seifert, Michael Nader, Lukas Kessler, Jens T. Siveke, Katharina Lueckerath, Stefan Kasper, Ken Herrmann, Nader Hirmas, Hartmut H. Schmidt, Rainer Hamacher and Wolfgang P. Fendler
    Journal of Nuclear Medicine April 6, 2023, jnumed.122.265215; DOI: https://doi.org/10.2967/jnumed.122.265215
  • You have access
    Addition of Peptide Receptor Radiotherapy to Immune Checkpoint Inhibition Therapy Improves Outcomes in Neuroendocrine Tumors
    Shadi A. Esfahani, Carolina De Aguiar Ferreira, Priska Summer, Umar Mahmood and Pedram Heidari
    Journal of Nuclear Medicine April 6, 2023, jnumed.123.265391; DOI: https://doi.org/10.2967/jnumed.123.265391
  • You have access
    Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3–Expressing Liver Cancer by Immuno-PET
    Stanley Fayn, A. Paden King, Nicholas T. Gutsche, Zhijian Duan, Jesse Buffington, Colleen P. Olkowski, Ying Fu, Jessica Hong, Deepak Sail, Kwamena E. Baidoo, Rolf E. Swenson, Ross W. Cheloha, Mitchell Ho, Peter Choyke and Freddy Escorcia
    Journal of Nuclear Medicine March 30, 2023, jnumed.122.265171; DOI: https://doi.org/10.2967/jnumed.122.265171
  • Prospective Phase II Trial of [<sup>68</sup>Ga]Ga-NODAGA-E[c(RGDyK)]<sub>2</sub> PET/CT Imaging of Integrin α<sub>v</sub>β<sub>3</sub> for Prognostication in Patients with Neuroendocrine Neoplasms
    You have access
    Prospective Phase II Trial of [68Ga]Ga-NODAGA-E[c(RGDyK)]2 PET/CT Imaging of Integrin αvβ3 for Prognostication in Patients with Neuroendocrine Neoplasms
    Esben Andreas Carlsen, Mathias Loft, Annika Loft, Dorota Czyzewska, Mikkel Andreassen, Seppo W. Langer, Ulrich Knigge and Andreas Kjaer
    Journal of Nuclear Medicine February 1, 2023, 64 (2) 252-259; DOI: https://doi.org/10.2967/jnumed.122.264383
  • You have access
    Brain Trauma Imaging
    Gérard N. Bischof and Donna J. Cross
    Journal of Nuclear Medicine January 1, 2023, 64 (1) 20-29; DOI: https://doi.org/10.2967/jnumed.121.263293
  • You have access
    Fibroblast Activation Protein Inhibitor Imaging in Nonmalignant Diseases: A New Perspective for Molecular Imaging
    Christian Schmidkonz, Torsten Kuwert, Armin Atzinger, Michael Cordes, Georg Schett, Andreas Ramming and Theresa Götz
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 1786-1792; DOI: https://doi.org/10.2967/jnumed.122.264205
  • You have access
    Nanoparticle Diagnostics and Theranostics in the Clinic
    Roger M. Pallares, Felix M. Mottaghy, Volkmar Schulz, Fabian Kiessling and Twan Lammers
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 1802-1808; DOI: https://doi.org/10.2967/jnumed.122.263895
  • Dynamic Tumor-Specific MHC-II Immuno-PET Predicts the Efficacy of Checkpoint Inhibitor Immunotherapy in Melanoma
    You have access
    Dynamic Tumor-Specific MHC-II Immuno-PET Predicts the Efficacy of Checkpoint Inhibitor Immunotherapy in Melanoma
    Zhen Yang, Feng Li, Yuqian Huang, Na Yin, Junjun Chu, Ying Ma, Roderic I. Pettigrew, Dale J. Hamilton, Diego R. Martin and Zheng Li
    Journal of Nuclear Medicine November 1, 2022, 63 (11) 1708-1714; DOI: https://doi.org/10.2967/jnumed.121.263151
  • Tracking Innate Immune Activation in a Mouse Model of Parkinson’s Disease Using TREM1 and TSPO PET Tracers
    You have access
    Tracking Innate Immune Activation in a Mouse Model of Parkinson’s Disease Using TREM1 and TSPO PET Tracers
    Katherine L. Lucot, Marc Y. Stevens, T. Adam Bonham, E. Carmen Azevedo, Aisling M. Chaney, Ebony D. Webber, Poorva Jain, Jessica L. Klockow, Isaac M. Jackson, Mackenzie L. Carlson, Edward E. Graves, Thomas J. Montine and Michelle L. James
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 1570-1578; DOI: https://doi.org/10.2967/jnumed.121.263039
  • Prospective Phase II Trial of Prognostication by <sup>68</sup>Ga-NOTA-AE105 uPAR PET in Patients with Neuroendocrine Neoplasms: Implications for uPAR-Targeted Therapy
    You have access
    Prospective Phase II Trial of Prognostication by 68Ga-NOTA-AE105 uPAR PET in Patients with Neuroendocrine Neoplasms: Implications for uPAR-Targeted Therapy
    Esben Andreas Carlsen, Mathias Loft, Annika Loft, Anne Kiil Berthelsen, Seppo W. Langer, Ulrich Knigge and Andreas Kjaer
    Journal of Nuclear Medicine September 1, 2022, 63 (9) 1371-1377; DOI: https://doi.org/10.2967/jnumed.121.263177

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 18
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire